SELZENTRY Drug Profile, 2020

$499.00

SELZENTRY Drug Profile, 2020

This report focuses on SELZENTRY and covers the following critical aspects of this drug:

  • United States patents
  • Expired United States patents
  • FDA Paragraph IV patent challenges
  • European supplementary protection certificates (SPCs)
  • Clinical trials
  • Drug prices
  • Finished product suppliers
  • Raw active pharmaceutical ingredient (API) sources
SKU: 022128 Category:

Description

SELZENTRY Drug Profile, 2020

This report focuses on SELZENTRY and covers the following critical aspects of this drug:

  • United States patents
  • Expired United States patents
  • FDA Paragraph IV patent challenges
  • European supplementary protection certificates (SPCs)
  • Clinical trials
  • Drug prices
  • Finished product suppliers
  • Raw active pharmaceutical ingredient (API) sources

Contents

  • Profile for SELZENTRY
  • US Patents
  • Expired US Patents
  • Paragraph IV Patent Challenges
  • International (exUS) Patents
  • Supplementary Protection Certificates
  • Clinical Trials
  • Drug Prices – Average Pharmacy Cost
  • Finished Product Suppliers
  • Bulk API Sources